Clinical Trial Update: Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

View source ↗

Summary

A completed clinical trial evaluating detection of abnormal blood clotting (thromboembolism) in patients with metastatic cancer undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Thromboembolism

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific | Status: COMPLETED